Late-Onset Peanut Allergy: Diagnosis and Management
For late-onset peanut allergy, confirm the diagnosis with skin prick testing (SPT) and peanut-specific IgE, supplemented by component-resolved diagnostics (particularly Ara h 2), and consider oral food challenge if results are equivocal, as many adults with childhood peanut allergy labels may have developed tolerance. 1, 2
Diagnostic Approach
Initial Testing Strategy
Start with SPT and serum peanut-specific IgE as first-line diagnostic tests 1, 2. The interpretation differs significantly from childhood allergy:
- SPT ≥8 mm or specific IgE ≥15 kU/L is highly predictive of clinical peanut allergy 1
- A negative test effectively excludes peanut allergy 2
- Intermediate positive results require further evaluation
Component-Resolved Diagnostics (CRD)
For intermediate results, measure Ara h 2 as a second-step test 2, 3:
- Ara h 2 positivity indicates genuine peanut allergy with higher specificity
- Isolated Ara h 8 sensitization suggests pollen food syndrome rather than true peanut allergy, typically presenting with mild oral/pharyngeal symptoms in patients with hay fever 1, 3
- This distinction is critical as Ara h 8-only sensitization rarely causes systemic reactions
Oral Food Challenge
OFC remains the gold standard when history and testing are discordant 4, 2, 5. This is particularly relevant for late-onset presentations because:
- Adults may carry childhood peanut allergy labels despite developing tolerance 3
- SPT has higher sensitivity than specific IgE for detecting sensitization 5
- OFC can safely delabel patients, removing unnecessary dietary restrictions 3
Critical caveat: OFC should only be performed in supervised medical settings with immediate access to epinephrine, as it carries risk of severe reactions 4.
Management Framework
Avoidance Strategy
Once confirmed, strict peanut avoidance is the cornerstone of management 6, 1, 7. Provide:
- Comprehensive written avoidance advice including label reading, cross-contamination risks, and hidden sources
- Training for patient, family, and workplace contacts on recognizing early reaction signs 7
- Written emergency treatment plan 7
The evidence shows that structured management plans reduce reaction severity: in one prospective study, only 0.5% of patients had severe follow-up reactions after implementing comprehensive avoidance education, compared to 12% initially 7.
Emergency Medication Allocation
Prescribe epinephrine auto-injectors based on reaction severity 6, 7:
- Weight 10-25 kg: 0.15 mg epinephrine auto-injector
- Weight >25 kg: 0.3 mg epinephrine auto-injector
- Adjunctive medications: H1 antihistamines (diphenhydramine 1-2 mg/kg, max 50 mg) for mild cutaneous symptoms 6
Epinephrine is indicated for any respiratory, cardiovascular, or neurologic symptoms 6, 8. Doses may be repeated every 5-15 minutes as needed 6.
Cross-Reactivity Considerations
In vitro cross-sensitization between peanut and tree nuts is high, but clinical cross-reactivity is limited 5. Do not automatically restrict all tree nuts without confirming clinical allergy:
- Clinically relevant cross-reactivity patterns: pistachio/cashew and walnut/pecan 5
- Consider OFC for tree nuts the patient has never ingested to avoid unnecessary dietary restrictions 5
- This approach reduces overdiagnosis and improves quality of life
Key Clinical Pitfalls
Do not rely solely on specific IgE levels: SPT has higher sensitivity, and test results must be interpreted with clinical history 1, 5
Distinguish pollen food syndrome from true peanut allergy: Isolated Ara h 8 sensitization typically causes only mild oral symptoms and does not require epinephrine 1, 3
Reassess long-standing diagnoses: Adults with childhood peanut allergy labels who report asymptomatic ingestion should be formally re-evaluated, as tolerance may have developed 3
Severity of testing does not predict reaction severity: The magnitude of SPT or specific IgE relates to probability of allergy, not clinical severity of future reactions 1
Regular retraining is essential: Patients require ongoing education on emergency medication administration 1, 7
Natural History Context
Unlike childhood peanut allergy where early introduction prevents disease 9, late-onset peanut allergy typically persists 6. Historical data shows minimal spontaneous resolution in established peanut allergy 6, making accurate initial diagnosis critical to avoid lifelong unnecessary restrictions.